Kai Chen
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Real-World Treatment Patterns, HER2 Testing Practices, and Clinical Outcomes in HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer.
Journal: Advances in therapy
Published: February 12, 2026
Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.
Journal: Future oncology (London, England)
Published: December 29, 2025
Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial.
Journal: Annals of surgical oncology
Published: November 05, 2025
Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy.
Journal: Cell host & microbe
Published: September 30, 2025
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: August 01, 2025
TRIM59 regulates autophagy-dependent ferroptosis in non-small cell lung cancer by modulating the ubiquitination of TMEM164.
Journal: Bioscience, biotechnology, and biochemistry
Published: March 07, 2025
Impact of coronavirus disease 2019 on surgery in patients with early-stage lung cancer: the COVIDLungSurg prospective cohort study.
Journal: Translational lung cancer research
Published: December 29, 2024
Immunogenic cell death-related genes predict prognosis and response to immunotherapy in lung squamous cell carcinoma.
Journal: Biotechnology and applied biochemistry
Published: April 30, 2024
Three-dimensional reconstruction computed tomography in thoracoscopic segmentectomy: a randomized controlled trial.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: February 28, 2024
Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics.
Journal: Cancer medicine
Published: January 06, 2024
Semaphorin4A promotes lung cancer by activation of NF-κB pathway mediated by PlexinB1.
Journal: PeerJ
Published: August 04, 2023
Peripheral absolute eosinophil count identifies the risk of serious immune-related adverse events in non-small cell lung cancer.
Journal: Frontiers in oncology
Published: July 27, 2022
Last Updated: 09/26/2026